Evidence map›Paper›PMID 26921299›Full record

ArticleG3 (Bethesda, Md.)2016

Novel Interactome of Saccharomyces cerevisiae Myosin Type II Identified by a Modified Integrated Membrane Yeast Two-Hybrid (iMYTH) Screen.

Ednalise Santiago, Pearl Akamine, Jamie Snider, Victoria Wong, Matthew Jessulat, Viktor Deineko, Alla Gagarinova, Hiroyuki Aoki, Zoran Minic, Sadhna Phanse and 6 more

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Ednalise SantiagoDepartment of Biochemistry,University of Puerto Rico, San Juan, Puerto Rico 00936-5067.
Pearl AkamineDepartment of Biochemistry,University of Puerto Rico, San Juan, Puerto Rico 00936-5067 Center for Molecular Sciences and Research, University of Puerto Rico, San Juan, Puerto Rico 00926.
Jamie SniderDepartment of Biochemistry, Department of Molecular Genetics, Donnelly Centre, University of Toronto, Ontario M5S 3E1, Canada.
Victoria WongDepartment of Biochemistry, Department of Molecular Genetics, Donnelly Centre, University of Toronto, Ontario M5S 3E1, Canada.
Matthew JessulatDepartment of Biochemistry, University of Regina, Saskatchewan, Canada.
Viktor DeinekoDepartment of Biochemistry, University of Regina, Saskatchewan, Canada.
Alla GagarinovaDepartment of Biochemistry, College of Medicine, University of Saskatchewan, Canada.
Hiroyuki AokiDepartment of Biochemistry, University of Regina, Saskatchewan, Canada.
Zoran MinicDepartment of Biochemistry, University of Regina, Saskatchewan, Canada.
Sadhna PhanseDepartment of Biochemistry, University of Regina, Saskatchewan, Canada.
Andrea San AntonioDepartment of Biochemistry,University of Puerto Rico, San Juan, Puerto Rico 00936-5067.
Luis A CubanoSchool of Medicine, Universidad Central del Caribe, Bayamon, Puerto Rico 00960-6032.
Brian C RymondDepartment of Biology, University of Kentucky, Lexington, Kentucky 40506.
Mohan BabuDepartment of Biochemistry, University of Regina, Saskatchewan, Canada.
Igor StagljarDepartment of Biochemistry, Department of Molecular Genetics, Donnelly Centre, University of Toronto, Ontario M5S 3E1, Canada.
Jose R Rodriguez-MedinaDepartment of Biochemistry,University of Puerto Rico, San Juan, Puerto Rico 00936-5067 jose.rodriguez123@upr.edu.
University of Regina · CAUniversity of Puerto Rico System · PRUniversity of Toronto · CACentral University of the Caribbean · PRUniversity of Kentucky · USUniversity of Saskatchewan · CA

Funding

SCIENCE AND TECHNOLOGY COMPETENCY & EDUCATION CORE (STCE)P20GM103475 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI CARMEN LYDIA CADILLA · 2012 to 2026
$52.9M
RISE Option III: MBRS RISE at the UPR Medical Sciences CampusR25GM061838 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI CADILLA, CARMEN LYDIA · 2000 to 2021
$25.5M
TECHNOLOGIES AND RESOURCES FOR CORE LABORATORIESU54MD007587 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI LUCIANO, CARLOS A., NOBOA, CARIAMARIE · 2012 to 2018
$23.2M
STEERING COMMITTEEU54MD008149 · NIMHD · MOREHOUSE SCHOOL OF MEDICINE · PI OFILI, ELIZABETH O. · 2012 to 2018
$21.1M
TRANSLATIONAL PROTEOMICS CENTERG12MD007600 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI FERNANDEZ-REPOLLET, EMMA · 2012 to 2016
$11.0M
NIGMS NIH HHS P20 GM103475NIGMS NIH HHS R25 GM061838NIMHD NIH HHS G12 MD007600NIMHD NIH HHS U54 MD007587NIMHD NIH HHS U54 MD008149
6 · The paper itself

Abstract

Nonmuscle myosin type II (Myo1p) is required for cytokinesis in the budding yeast Saccharomyces cerevisiae Loss of Myo1p activity has been associated with growth abnormalities and enhanced sensitivity to osmotic stress, making it an appealing antifungal therapeutic target. The Myo1p tail-only domain was previously reported to have functional activity equivalent to the full-length Myo1p whereas the head-only domain did not. Since Myo1p tail-only constructs are biologically active, the tail domain must have additional functions beyond its previously described role in myosin dimerization or trimerization. The identification of new Myo1p-interacting proteins may shed light on the other functions of the Myo1p tail domain. To identify novel Myo1p-interacting proteins, and determine if Myo1p can serve as a scaffold to recruit proteins to the bud neck during cytokinesis, we used the integrated split-ubiquitin membrane yeast two-hybrid (iMYTH) system. Myo1p was iMYTH-tagged at its C-terminus, and screened against both cDNA and genomic prey libraries to identify interacting proteins. Control experiments showed that the Myo1p-bait construct was appropriately expressed, and that the protein colocalized to the yeast bud neck. Thirty novel Myo1p-interacting proteins were identified by iMYTH. Eight proteins were confirmed by coprecipitation (Ape2, Bzz1, Fba1, Pdi1, Rpl5, Tah11, and Trx2) or mass spectrometry (AP-MS) (Abp1). The novel Myo1p-interacting proteins identified come from a range of different processes, including cellular organization and protein synthesis. Actin assembly/disassembly factors such as the SH3 domain protein Bzz1 and the actin-binding protein Abp1 represent likely Myo1p interactions during cytokinesis.

Indexed as

Protein Interaction MappingProtein Interaction MapsImmunoprecipitationMyosin Type IIProteomicsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTwo-Hybrid System TechniquesMyosin Type IISaccharomyces cerevisiae ProteinscytokinesisinteractomeMyo1pproteomicsyeast

Identifiers

PMID26921299
PMCPMC4856097
OpenAlexW2301866685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.